Rameda Pharmaceuticals
Moustafa Khallaf is an accomplished IT professional with extensive experience in network and infrastructure management, currently serving as the Infrastructure Section Head and Senior Network and Collaboration Engineer at Rameda Pharmaceuticals since February 2015. Moustafa oversees network operations for over 1,200 employees across more than 7 branches in Egypt, managing and configuring various Cisco network devices, including routers and switches. Prior roles include Network Engineer at Watheeqa Securities Brokerage Co, where Moustafa worked on Microsoft systems and VLAN configurations, and Network & System Engineer at Al-Kawthar School, focusing on computer maintenance and resource estimation. Moustafa began their career as an IT Specialist at Vantage Travel Agency, establishing computer and telephone networks. Moustafa holds a Bachelor of Engineering in Electrical and Electronics Engineering from Thebes Academy.
This person is not in any offices
Rameda Pharmaceuticals
Our Vision: To become the most valuable emerging pharmaceutical company in Egypt. Our Mission: To provide our customers quality health care solutions in a cost effective manner by developing products and services that satisfy their health requirements. Establishment Rameda began operations in 1994 and was established by a group of Gulf investors with the intention of creating one of the largest pharmaceutical operations in the region. Owners hired V-Konsult of Germany to create a state-of-the art design. Contracted British Carter Construction company to build the Rameda’s facilities. Partnership with Alcon In 1999, Rameda entered into an agreement with Alcon to manufacture – under license - their ophthalmology products. In order to guarantee the quality of their products, Alcon built one of the highest quality eye production facilities in the region at Rameda. Quality enhancement Rameda renewed the syrup production to become GMP (Good Manufacturing Practice). A new Beginning In 2011, Compass Capital led a consortium of private equity investors for the acquisition of 100% of Rameda. Compass Capital plans to establish Rameda as a regional leader in the industry. To execute this strategy Rameda hired a new management team with a proven track record to complement the existing team. Company has commissioned M+W Group to transform solid dosage and beta lactam areas into GMP. Brining entire facility to compliance.